Another study suggested that mutation of NSD1 or NSD2 leads to significantly better clinical outcomes in HPV- HNSCC of the larynx [25], further supporting an oncogenic role for these methyltransferases in HPV- HNSCC. Here, NSD2 is linked to head and neck squamous cell carcinoma.